Amphibian antimicrobial peptide fallaxin analogue FL9 affects virulence gene expression and DNA replication in Staphylococcus aureus

Journal of Medical Microbiology

Volumn 64, Issue 12, 2015, Pages 1504-1513

  Gottschalk, Sanne ^a,c   Gottlieb, Caroline T ^b,d   Vestergaard, Martin ^a   Hansen, Paul R ^a   Gram, Lone ^b   Ingmer, Hanne ^a   Thomsen, Line E ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^c NOVO NORDISK A S   (Denmark)

^d CHR HANSEN A S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA HEMOLYSIN; CIPROFLOXACIN; FL 9; POLYPEPTIDE ANTIBIOTIC AGENT; STAPHYLOKINASE; UNCLASSIFIED DRUG; ANTIMICROBIAL CATIONIC PEPTIDE; BACTERIAL DNA; BACTERIAL PROTEIN; FL9 PEPTIDE; VIRULENCE FACTOR;

ACIDITY; ALKALINITY; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL MEMBRANE; BACTERIAL VIRULENCE; CELL MEMBRANE PERMEABILITY; CELL SURFACE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; DNA REPLICATION; DNA SYNTHESIS; DRUG DNA BINDING; GENE EXPRESSION; IN VITRO STUDY; LIMIT OF DETECTION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RECA GENE; SALT STRESS; ANTIBIOTIC RESISTANCE; CELL MEMBRANE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MICROBIAL SENSITIVITY TEST; STAPHYLOCOCCUS AUREUS;

ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIAL PROTEINS; CELL MEMBRANE; DNA REPLICATION; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; GENE EXPRESSION REGULATION, BACTERIAL; MICROBIAL SENSITIVITY TESTS; SOS RESPONSE (GENETICS); STAPHYLOCOCCUS AUREUS; VIRULENCE FACTORS;

EID: 84955582598     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.00177     Document Type: Article

References (58)

1. Bernardo, K., Pakulat, N., Fleer, S., Schnaith, A., Utermöhlen, O., Krut, O., Müller, S. & Krönke, M. (2004). Subinhibitory concentrations of linezolid reduce Staphylococcus aureus virulence factor expression. Antimicrob Agents Chemother 48, 546-555.
2. Bokarewa, M. I., Jin, T. & Tarkowski, A. (2006). Staphylococcus aureus: Staphylokinase. Int J Biochem Cell Biol 38, 504-509.
3. Boucher, H. W., Talbot, G. H., Bradley, J. S., Edwards, J. E., Gilbert, D., Rice, L. B., Scheld, M., Spellberg, B. & Bartlett, J. (2009). Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis 48, 1-12.
4. Brogden, K. A. (2005). Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol 3, 238-250.
5. Chan, P. F. & Foster, S. J. (1998). The role of environmental factors in the regulation of virulence-determinant expression in Staphylococcus aureus 8325-4. Microbiology 144, 2469-2479.
6. Cirz, R. T., Jones, M. B., Gingles, N. A., Minogue, T. D., Jarrahi, B., Peterson, S. N. & Romesberg, F. E. (2007). Complete and SOSmediated response of Staphylococcus aureus to the antibiotic ciprofloxacin. J Bacteriol 189, 531-539.
7. Cohn, M. T., Kjelgaard, P., Frees, D., Penadés, J. R. & Ingmer, H. (2011). Clp-dependent proteolysis of the LexA N-terminal domain in Staphylococcus aureus. Microbiology 157, 677-684.
8. Corrigan, R. M. & Foster, T. J. (2009). An improved tetracyclineinducible expression vector for Staphylococcus aureus. Plasmid 61, 126-129.
9. Courcelle, J. & Hanawalt, P. C. (2003). RecA-dependent recovery of arrested DNA replication forks. Annu Rev Genet 37, 611-646.
10. Davies, J., Spiegelman, G. B. & Yim, G. (2006). The world of subinhibitory antibiotic concentrations. Curr Opin Microbiol 9, 445-453.
11. Diep, B. A., Gill, S. R., Chang, R. F., Phan, T. H., Chen, J. H., Davidson, M. G., Lin, F., Lin, J., Carleton, H. A. & other authors (2006). Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus. Lancet 367, 731-739.
12. Dubin, G. (2002). Extracellular proteases of Staphylococcus spp. Biol Chem 383, 1075-1086.
13. Falord, M., Mäder, U., Hiron, A., Débarbouillé, M. & Msadek, T. (2011). Investigation of the Staphylococcus aureus GraSR regulon reveals novel links to virulence, stress response and cell wall signal transduction pathways. PLoS One 6, e21323.
14. Goldfeder, Y., Zaknoon, F. & Mor, A. (2010). Experimental conditions that enhance potency of an antibacterial oligo-acyl-lysyl. Antimicrob Agents Chemother 54, 2590-2595.
15. Goldman, M. J., Anderson, G. M., Stolzenberg, E. D., Kari, U. P., Zasloff, M. & Wilson, J. M. (1997). Human β-defensin-1 is a saltsensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell 88, 553-560.
16. Gordon, Y. J., Romanowski, E. G. & McDermott, A. M. (2005). A review of antimicrobial peptides and their therapeutic potential as anti-infective drugs. Curr Eye Res 30, 505-515.
17. Gottschalk, S., Ifrah, D., Lerche, S., Gottlieb, C. T., Cohn, M. T., Hiasa, H., Hansen, P. R., Gram, L., Ingmer, H. & Thomsen, L. E. (2013). The antimicrobial lysine-peptoid hybrid LP5 inhibits DNA replication and induces the SOS response in Staphylococcus aureus. BMC Microbiol 13, 192.
18. Gunderson, C. W. & Segall, A. M. (2006). DNA repair, a novel antibacterial target: Holliday junction-trapping peptides induce DNA damage and chromosome segregation defects. Mol Microbiol 59, 1129-1148.
19. Herbert, S., Barry, P. & Novick, R. P. (2001). Subinhibitory clindamycin differentially inhibits transcription of exoprotein genes in Staphylococcus aureus. Infect Immun 69, 2996-3003.
20. Horsburgh, M. J., Aish, J. L., White, I. J., Shaw, L., Lithgow, J. K. & Foster, S. J. (2002). sB modulates virulence determinant expression and stress resistance: characterization of a functional rsbU strain derived from Staphylococcus aureus 8325-4. J Bacteriol 184, 5457-5467.
21. Huang, H. W. (2006). Molecular mechanism of antimicrobial peptides: the origin of cooperativity. Biochim Biophys Acta 1758, 1292-1302.
22. Iordanescu, S. & Surdeanu, M. (1976). Two restriction and modification systems in Staphylococcus aureus NCTC8325. J Gen Microbiol 96, 277-281.
23. Jenssen, H., Hamill, P. & Hancock, R. E. (2006). Peptide antimicrobial agents. Clin Microbiol Rev 19, 491-511.
24. Jin, T., Bokarewa, M., Foster, T., Mitchell, J., Higgins, J. & Tarkowski, A. (2004). Staphylococcus aureus resists human defensins by production of staphylokinase, a novel bacterial evasion mechanism. J Immunol 172, 1169-1176.
25. Karlsson, A., Saravia-Otten, P., Tegmark, K., Morfeldt, E. & Arvidson, S. (2001). Decreased amounts of cell wall-associated protein A and fibronectin-binding proteins in Staphylococcus aureus sarA mutants due to up-regulation of extracellular proteases. Infect Immun 69, 4742-4748.
26. Kobayashi, S., Takeshima, K., Park, C. B., Kim, S. C. & Matsuzaki, K. (2000). Interactions of the novel antimicrobial peptide buforin 2 with lipid bilayers: proline as a translocation promoting factor. Biochemistry 39, 8648-8654.
27. Lee, I. H., Cho, Y. & Lehrer, R. I. (1997). Effects of pH and salinity on the antimicrobial properties of clavanins. Infect Immun 65, 2898-2903.
28. Lehrer, R. I., Rosenman, M., Harwig, S. S., Jackson, R. & Eisenhauer, P. (1991). Ultrasensitive assays for endogenous antimicrobial polypeptides. J Immunol Methods 137, 167-173.
29. Li, M., Cha, D. J., Lai, Y., Villaruz, A. E., Sturdevant, D. E. & Otto, M. (2007). The antimicrobial peptide-sensing system aps of Staphylococcus aureus. Mol Microbiol 66, 1136-1147.
30. Makobongo, M. O., Gancz, H., Carpenter, B. M., McDaniel, D. P. & Merrell, D. S. (2012). The oligo-acyl lysyl antimicrobial peptide C12K-2b12 exhibits a dual mechanism of action and demonstrates strong in vivo efficacy against Helicobacter pylori. Antimicrob Agents Chemother 56, 378-390.
31. Mercer, D. K. & O’Neil, D. A. (2013). Peptides as the next generation of anti-infectives. Future Med Chem 5, 315-337.
32. Minahk, C. J. & Morero, R. D. (2003). Inhibition of enterocin CRL35 antibiotic activity by mono- and divalent ions. Lett Appl Microbiol 37, 374-379.
33. Nielsen, A., Nielsen, K. F., Frees, D., Larsen, T. O. & Ingmer, H. (2010). Method for screening compounds that influence virulence gene expression in Staphylococcus aureus. Antimicrob Agents Chemother 54, 509-512.
34. Nielsen, L. N., Roggenbuck, M., Haaber, J., Ifrah, D. & Ingmer, H. (2012). Diverse modulation of spa transcription by cell wall active antibiotics in Staphylococcus aureus. BMC Res Notes 5, 457.
35. Nielsen, S. L., Frimodt-Moller, N., Kragelund, B. B. & Hansen, P. R. (2007). Structure-activity study of the antibacterial peptide fallaxin. Protein Sci 16, 1969-1976.
36. Novick, R. (1967). Properties of a cryptic high-frequency transducing phage in Staphylococcus aureus. Virology 33, 155-166.
37. Ohlsen, K., Ziebuhr, W., Koller, K. P., Hell, W., Wichelhaus, T. A. & Hacker, J. (1998). Effects of subinhibitory concentrations of antibiotics on a-toxin (hla) gene expression of methicillin-sensitiveand methicillin-resistant Staphylococcus aureus isolates. Antimicrob Agents Chemother 42, 2817-2823.
38. Park, C. B., Kim, H. S. & Kim, S. C. (1998). Mechanism of action of the antimicrobial peptide buforin II: buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions. Biochem Biophys Res Commun 244, 253-257.
39. Pasupuleti, M., Schmidtchen, A. & Malmsten, M. (2012). Antimicrobial peptides: key components of the innate immune system. Crit Rev Biotechnol 32, 143-171.
40. Patrzykat, A., Friedrich, C. L., Zhang, L., Mendoza, V. & Hancock, R. E. W. (2002). Sublethal concentrations of pleurocidin-derived antimicrobial peptides inhibit macromolecular synthesis in Escherichia coli. Antimicrob Agents Chemother 46, 605-614.
41. Peschel, A. & Sahl, H. G. (2006). The co-evolution of host cationic antimicrobial peptides and microbial resistance. Nat Rev Microbiol 4, 529-536.
42. Peschel, A., Otto, M., Jack, R. W., Kalbacher, H., Jung, G. & Götz, F. (1999). Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides. J Biol Chem 274, 8405-8410.
43. Peschel, A., Jack, R. W., Otto, M., Collins, L. V., Staubitz, P., Nicholson, G., Kalbacher, H., Nieuwenhuizen, W. F., Jung, G. & other authors (2001). Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with l-lysine. J Exp Med 193, 1067-1076.
44. Radzishevsky, I. S., Rotem, S., Zaknoon, F., Gaidukov, L., Dagan, A. & Mor, A. (2005). Effects of acyl versus aminoacyl conjugation on the properties of antimicrobial peptides. Antimicrob Agents Chemother 49, 2412-2420.
45. Rollins-Smith, L. A., King, J. D., Nielsen, P. F., Sonnevend, A. & Conlon, J. M. (2005). An antimicrobial peptide from the skin secretions of the mountain chicken frog Leptodactylus fallax (Anura: Leptodactylidae). Regul Pept 124, 173-178.
46. Rotem, S., Radzishevsky, I. S., Bourdetsky, D., Navon-Venezia, S., Carmeli, Y. & Mor, A. (2008). Analogous oligo-acyl-lysines with distinct antibacterial mechanisms. FASEB J 22, 2652-2661.
47. Rozek, A., Powers, J. P., Friedrich, C. L. & Hancock, R. E. (2003). Structure-based design of an indolicidin peptide analogue with increased protease stability. Biochemistry 42, 14130-14138.
48. Rydlo, T., Rotem, S. & Mor, A. (2006). Antibacterial properties of dermaseptin S4 derivatives under extreme incubation conditions. Antimicrob Agents Chemother 50, 490-497.
49. Sahl, H. G., Pag, U., Bonness, S., Wagner, S., Antcheva, N. & Tossi, A. (2005). Mammalian defensins: structures and mechanism of antibiotic activity. J Leukoc Biol 77, 466-475.
50. Sambrook, J. & Russel, D. W. (2001). Molecular Cloning: a Laboratory Manual, 3rd edn. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
51. Sarig, H., Goldfeder, Y., Rotem, S. & Mor, A. (2011). Mechanisms mediating bactericidal properties and conditions that enhance the potency of a broad-spectrum oligo-acyl-lysyl. Antimicrob Agents Chemother 55, 688-695.
52. Sieprawska-Lupa, M., Mydel, P., Krawczyk, K., Wójcik, K., Puklo, M., Lupa, B., Suder, P., Silberring, J., Reed, M. & other authors (2004). Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases. Antimicrob Agents Chemother 48, 4673-4679.
53. Smith, B. T. & Walker, G. C. (1998). Mutagenesis and more: umuDC and the Escherichia coli SOS response. Genetics 148, 1599-1610.
54. Su, L. Y., Willner, D. L. & Segall, A. M. (2010). An antimicrobial peptide that targets DNA repair intermediates in vitro inhibits Salmonella growth within murine macrophages. Antimicrob Agents Chemother 54, 1888-1899.
55. Thomsen, L. E., Gottlieb, C. T., Gottschalk, S., Wodskou, T. T., Kristensen, H. H., Gram, L. & Ingmer, H. (2010). The heme sensing response regulator HssR in Staphylococcus aureus but not the homologous RR23 in Listeria monocytogenes modulates susceptibility to the antimicrobial peptide plectasin. BMC Microbiol 10, 307.
56. Worlitzsch, D., Kaygin, H., Steinhuber, A., Dalhoff, A., Botzenhart, K. & Do¨ring, G. (2001). Effects of amoxicillin, gentamicin, and moxi-floxacin on the hemolytic activity of Staphylococcus aureus in vitro and in vivo. Antimicrob Agents Chemother 45, 196-202.
57. Yaron, S., Rydlo, T., Shachar, D. & Mor, A. (2003).Activity of dermaseptin K4-S4 against foodborne pathogens. Peptides 24, 1815-1821.
58. Zasloff, M. (2002). Antimicrobial peptides of multicellular organisms. Nature 415, 389-395.